FRHC Q1 2026 Earnings Robust EPS of 125 Drives Stock Higher AGIO Q1 2026 Earnings Narrower Loss Per Share Highlights Improving Cost Management TG Therapeutics Q1 2026 Earnings EPS Misses Expectations Despite Stock Gain DPRO Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges VENU Q1 2026 Earnings EPS Falls Sharply Short of Estimates Amid Operational Headwinds